Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$634.89M
Total Bought:
$164.22M
Total Sold:
$101.13M
Net Transaction:
+$63.08M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Xenon Pharmaceuticals Inc.(XENE)837,387994,227+156,840$36.05M$38.76M6.11%+$2.72M
Apogee Therapeutics Inc592,093836,283+244,190$39.34M$32.91M5.18%-$6.44M
Madrigal Pharmaceuticals, Inc.(MDGL)115,000110,000-5,000$30.71M$30.82M4.85%+$108.0K
Arcellx Inc
COMMON STOCK
300,000460,000+160,000$20.86M$25.39M4.00%+$4.52M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,400,0001,450,000+50,000$19.75M$23.56M3.71%+$3.81M
Crinetics Pharmaceuticals In470,000515,000+45,000$22.00M$23.07M3.63%+$1.07M
Cerevel Therapeutics Hldng I300,000500,000+200,000$12.68M$20.45M3.22%+$7.76M
Nurix Therapeutics, Inc.(NRIX)810,253912,000+101,747$11.91M$19.03M3.00%+$7.12M
Celldex Therapeutics, Inc.(CLDX)510,000475,400-34,600$21.40M$17.59M2.77%-$3.81M
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$18.30M$17.26M2.72%-$1.04M
Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY)000$9.45M$16.20M2.55%+$6.75M
BeOne Medicines AGADR(ONC)82,143110,000+27,857$12.85M$15.69M2.47%+$2.85M
Alkermes plcSHS(ALKS)75,000650,000+575,000$2.03M$15.66M2.47%+$13.63M
Nuvalent Inc150,000200,000+50,000$11.26M$15.17M2.39%+$3.91M
Autolus Therapeutics plcADS(AUTL)3,375,0004,300,000+925,000$21.53M$14.96M2.36%-$6.57M
Vera Therapeutics, Inc.CL A(VERA)470,000375,000-95,000$20.27M$13.57M2.14%-$6.70M
Kura Oncology, Inc.(KURA)730,492650,000-80,492$15.58M$13.38M2.11%-$2.20M
Inozyme Pharma Inc2,642,5192,856,252+213,733$20.24M$12.74M2.01%-$7.50M
Spyre Therapeutics, Inc.(SYRE)410,000513,420+103,420$15.55M$12.07M1.90%-$3.48M
Climb Bio, Inc.(CLYM)01,670,661+1,670,661$0$11.88M1.87%+$11.88M
Centessa Pharmaceuticals PlcADS830,5461,135,702+305,156$9.39M$10.26M1.62%+$870.2K
Establishment Labs Holdings Inc.(ESTA)164,589223,407+58,818$8.38M$10.15M1.60%+$1.77M
Verona Pharma PlcADS817,833700,000-117,833$13.16M$10.12M1.59%-$3.04M
Inari Med Inc175,000200,000+25,000$8.40M$9.63M1.52%+$1.23M
Immunovant, Inc.(IMVT)285,000346,088+61,088$9.21M$9.14M1.44%-$71.6K
Astria Therapeutics Inc845,606975,606+130,000$11.90M$8.88M1.40%-$3.02M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$5.78M$8.64M1.36%+$2.85M
Morphic Hldg Inc225,000250,573+25,573$7.92M$8.54M1.34%+$617.0K
Insmed Incorporated(INSM)0125,000+125,000$0$8.38M1.32%+$8.38M
Newamsterdam Pharma Company
ORDINARY SHARES
286,200423,155+136,955$6.77M$8.13M1.28%+$1.36M
Omeros CorpNOTE 5 250 2 1000$7.63M$8.08M1.27%+$450.6K
Rezolute, Inc.(RZLT)1,600,0001,850,000+250,000$4.08M$7.96M1.25%+$3.88M
Merus N V0125,000+125,000$0$7.40M1.16%+$7.40M
Axsome Therapeutics, Inc.(AXSM)139,75880,000-59,758$11.15M$6.44M1.01%-$4.71M
Geron Corporation(GERN)2,500,0001,500,000-1,000,000$8.25M$6.36M1.00%-$1.89M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$0$6.30M0.99%+$6.30M
Savara Inc.(SVRA)1,150,0001,546,850+396,850$5.73M$6.23M0.98%+$506.8K
Erasca, Inc.(ERAS)02,499,431+2,499,431$0$5.90M0.93%+$5.90M
Perspective Therapeutics, Inc.(CATX)0550,000+550,000$0$5.48M0.86%+$5.48M
Mirum Pharmaceuticals, Inc.(MIRM)160,000155,000-5,000$4.02M$5.30M0.83%+$1.28M
Cullinan Therapeutics, Inc.(CGEM)258,588263,817+5,229$4.41M$4.60M0.72%+$194.6K
Vaxcyte, Inc.(PCVX)80,00060,000-20,000$5.46M$4.53M0.71%-$934.2K
Elevation Oncology Inc1,268,8251,468,825+200,000$6.51M$3.97M0.62%-$2.54M
Hillevax Inc0265,859+265,859$0$3.84M0.61%+$3.84M
Mineralys Therapeutics, Inc.(MLYS)327,959327,9590$4.23M$3.84M0.60%-$396.8K
Roivant Sciences Ltd.SHS(ROIV)500,000351,587-148,413$5.27M$3.72M0.59%-$1.55M
Dyne Therapeutics, Inc.(DYN)0100,000+100,000$0$3.53M0.56%+$3.53M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
0350,000+350,000$0$3.52M0.55%+$3.52M
Immatics N.V.SHS(IMTX)350,000300,000-50,000$3.68M$3.49M0.55%-$192.5K
Spdr Ser TrS P BIOTECH
ST STR SP BIOT
037,550+37,550$0$3.48M0.55%+$3.48M
Context Therapeutics Inc.(CNTX)328,8171,619,140+1,290,323$453.8K$3.25M0.51%+$2.79M
Black Diamond Therapeutics I0650,000+650,000$0$3.03M0.48%+$3.03M
COMPASS Pathways plcADS(CMPS)1,027,868500,512-527,356$8.55M$3.02M0.48%-$5.53M
Olema Pharmaceuticals, Inc.(OLMA)0275,000+275,000$0$2.98M0.47%+$2.98M
Nextcure Inc1,359,0371,687,955+328,918$3.03M$2.68M0.42%-$346.8K
Springworks Therapeutics Inc100,00069,999-30,001$4.92M$2.64M0.42%-$2.29M
Helix Acquisition Corp IiCL A250,000250,0000$2.59M$2.56M0.40%-$32.5K
BridgeBio Pharma, Inc.(BBIO)50,000100,000+50,000$1.55M$2.53M0.40%+$987.0K
Viridian Therapeutics, Inc.(VRDN)0150,000+150,000$0$1.95M0.31%+$1.95M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
202,599202,5990$2.24M$1.92M0.30%-$320.1K
Wave Life Sciences, Inc.SHS(WVE)286,585375,000+88,415$1.77M$1.87M0.29%+$103.0K
Vir Biotechnology, Inc.(VIR)0200,000+200,000$0$1.78M0.28%+$1.78M
Zymeworks Inc.(ZYME)0191,127+191,127$0$1.63M0.26%+$1.63M
Mersana Therapeutics Inc1,000,000767,000-233,000$4.48M$1.54M0.24%-$2.94M
Arya Sciences Acqu Corp IvCL A133,500133,5000$1.50M$1.53M0.24%+$25.4K
ADC Therapeutics SASHS(ADCT)0474,744+474,744$0$1.50M0.24%+$1.50M
Kyverna Therapeutics, Inc.(KYTX)0200,000+200,000$0$1.50M0.24%+$1.50M
Arrowhead Pharmaceuticals, Inc.(ARWR)120,00050,000-70,000$3.43M$1.30M0.20%-$2.13M
Tango Therapeutics, Inc.(TNGX)150,274150,2740$1.19M$1.29M0.20%+$96.2K
Nkarta, Inc.(NKTX)0200,000+200,000$0$1.18M0.19%+$1.18M
Kezar Life Sciences Inc1,761,7781,761,7780$1.59M$1.06M0.17%-$531.4K
Tectonic Therapeutic, Inc.(TECX)058,331+58,331$0$960.7K0.15%+$960.7K
Puma Biotechnology, Inc.(PBYI)0250,000+250,000$0$815.0K0.13%+$815.0K
Zura Bio LimitedCL A(ZURA)450,009223,335-226,674$1.16M$781.7K0.12%-$374.9K
Avalo Therapeutics, Inc.(AVTX)10,00045,000+35,000$217.5K$561.1K0.09%+$343.6K
Q32 Bio Inc.(QTTB)27,77727,7770$473.3K$498.6K0.08%+$25.3K
Immatics N.VW EXP 07 01 202187,204187,2040$486.7K$484.9K0.08%-$1.9K
Neurobo Pharmaceuticals In089,222+89,222$0$431.8K0.07%+$431.8K
Promis Neurosciences Inc265,958265,9580$508.0K$398.9K0.06%-$109.0K
Aerovate Therapeutics Inc0200,000+200,000$0$332.0K0.05%+$332.0K
Arca Biopharma Inc072,484+72,484$0$277.6K0.04%+$277.6K
Rapt Therapeutics Inc075,000+75,000$0$228.8K0.04%+$228.8K
Passage Bio, Inc.(PASG)264,266264,2660$356.8K$209.9K0.03%-$146.9K
Genelux Corporation(GNLX)0100,000+100,000$0$195.0K0.03%+$195.0K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)75,00075,0000$22.4K$4.5K0.00%-$17.9K
Iovance Biotherapeutics, Inc.(IOVA)0100+100$0$8020.00%+$802
Absci Corporation1,025,0000-1,025,000$5.82M$0—-$5.82M
Apellis Pharmaceuticals Inc
COM
165,0000-165,000$9.70M$0—-$9.70M
Avrobio Inc700,0000-700,000$896.0K$0—-$896.0K
Boston Scientific Corporation(BSX)25,0000-25,000$1.71M$0—-$1.71M
Cassava Sciences IncW EXP 11 15 20224,2000-24,200$97.5K$0—-$97.5K
Cytokinetics, Incorporated(CYTK)80,0000-80,000$5.61M$0—-$5.61M
Fulcrum Therapeutics, Inc.(FULC)550,3390-550,339$5.20M$0—-$5.20M
Intra-Cellular Therapies Inc50,0000-50,000$3.46M$0—-$3.46M
Krystal Biotech, Inc.(KRYS)26,7460-26,746$4.76M$0—-$4.76M
MoonLake ImmunotherapeuticsCL A(MLTX)75,0000-75,000$3.77M$0—-$3.77M
Perspective Therapeutics, Inc.(CATX)5,100,0000-5,100,000$6.07M$0—-$6.07M
Protagonist Therapeutics Inc100,0000-100,000$2.89M$0—-$2.89M
REGENXBIO Inc.(RGNX)110,0000-110,000$2.32M$0—-$2.32M
Terns Pharmaceuticals Inc450,0000-450,000$2.95M$0—-$2.95M
Page 1 of 2
Affinity Asset Advisors, LLC — 13F Holdings — Q2 2024 | TickerTrail